Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial

Lachmann, H, Lauwerys, B, Miettunen, P et al. (9 more authors) (2019) Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial. In: 2019 ACR/ARP Annual Meeting.

Metadata

Authors/Creators:
Dates:
  • Published: 10 November 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Jun 2020 11:39
Last Modified: 25 Jun 2020 11:39
Status: Published
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics